Literature DB >> 17088002

Garlic, hypertension and patient education.

Mustafa Capraz, Melda Dilek, Tekin Akpolat.   

Abstract

The aims of this study are to investigate the frequency of garlic usage in hypertensive population and to evaluate acute effect of garlic and garlic tablets on blood pressure in patients with hypertension. 4102 of the 7703 patients (53.3%) reported that they were using garlic. No significant effect on blood pressure was observed in any of the three groups (placebo, garlic or garlic tablets). Use of garlic is common among the hypertensive population, garlic and garlic tablets do not have acute blood pressure lowering effect, and a special education program informing patients and public about garlic is required.

Entities:  

Mesh:

Year:  2006        PMID: 17088002     DOI: 10.1016/j.ijcard.2006.08.060

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

1.  Herbal therapies used by hypertensive patients in Turkey.

Authors:  Zuhal Bahar; Sevgi Kızılcı; Ayşe Beşer; Dilek Büyükkaya Besen; Nihal Gördes; Fatma Ersin; Aygul Kissal; Cantürk Çapık
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-12-31

2.  Independent beneficial effects of aged garlic extract intake with regular exercise on cardiovascular risk in postmenopausal women.

Authors:  Dae Yun Seo; Sung Ryul Lee; Hyoung Kyu Kim; Yeong Ho Baek; Yi Sub Kwak; Tae Hee Ko; Nari Kim; Byoung Doo Rhee; Kyoung Soo Ko; Byung Joo Park; Jin Han
Journal:  Nutr Res Pract       Date:  2012-06-30       Impact factor: 1.926

Review 3.  Potential angiotensin converting enzyme (ACE) inhibitors from Iranian traditional plants described by Avicenna's Canon of Medicine.

Authors:  Seyede Zohre Kamrani Rad; Behjat Javadi; A Wallace Hayes; Gholamreza KarimI
Journal:  Avicenna J Phytomed       Date:  2019 Jul-Aug

4.  Role of garlic usage in cardiovascular disease prevention: an evidence-based approach.

Authors:  Waris Qidwai; Tabinda Ashfaq
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-17       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.